CLBS - Caladrius Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts4444
Avg. Estimate-0.39-0.4-1.56-0.93
Low Estimate-0.45-0.48-1.7-1.79
High Estimate-0.32-0.33-1.36-0.53
Year Ago EPS-0.49-0.47-1.88-1.56
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts4444
Avg. EstimateN/AN/AN/A5.18M
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/A15M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20199/29/201912/30/20193/30/2020
EPS Est.-0.44-0.43-0.34-0.29
EPS Actual-0.49-0.47-0.47-0.38
Difference-0.05-0.04-0.13-0.09
Surprise %-11.40%-9.30%-38.20%-31.00%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.39-0.4-1.56-0.93
7 Days Ago-0.39-0.4-1.56-0.93
30 Days Ago-0.39-0.4-1.56-0.93
60 Days Ago-0.29-0.3-1.2-0.44
90 Days Ago-0.29-0.3-1.2-0.44
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCLBSIndustrySector(s)S&P 500
Current Qtr.20.40%N/AN/AN/A
Next Qtr.14.90%N/AN/AN/A
Current Year17.00%N/AN/AN/A
Next Year40.40%N/AN/AN/A
Next 5 Years (per annum)60.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A